Chaitanya Iragavarapu

Markey Cancer Center — United States

Medicine · Health Sciences

8h-index508citations37works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(8), Chronic Lymphocytic Leukemia Research(8), Lymphoma Diagnosis and Treatment(7), CAR-T cell therapy research(7), Acute Lymphoblastic Leukemia research(5)

Publications37 total

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes
Blood·2025Open Access
Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia
Blood·2025
TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant
Blood·2025
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (<scp>AML</scp>) in Obese Patients
European Journal Of Haematology·2024
ALPHA3, a Pivotal Phase 2 Study of First-Line Consolidation with Cemacabtagene Ansegedleucel (Cema-Cel) in Patients with Large B-Cell Lymphoma and Minimal Residual Disease after Response to Standard Therapy
Blood·2024· 7 citedOpen Access
ALPHA3: A Pivotal Phase 2 Study Evaluating the Safety and Efficacy of First-Line (1L) Consolidation With Cemacabtagene Ansegedleucel (Cema-Cel) in Patients With Large B-Cell Lymphoma (LBCL) and Minimal Residual Disease (MRD) After Response to Standard Therapy
Clinical Lymphoma Myeloma & Leukemia·2024
CLL-189 Real-World Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients With Richter Transformation (RT) From the Center for International Blood and Marrow Transplant Research (CIBMTR)
Clinical Lymphoma Myeloma & Leukemia·2024
Real-World Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients With Richter Transformation (RT) From the Center for International Blood and Marrow Transplant Research (CIBMTR)
Clinical Lymphoma Myeloma & Leukemia·2024
CT-412 ALPHA3: A Pivotal Phase 2 Study Evaluating the Safety and Efficacy of First-Line (1L) Consolidation With Cemacabtagene Ansegedleucel (Cema-Cel) in Patients With Large B-Cell Lymphoma (LBCL) and Minimal Residual Disease (MRD) After Response to Standard Therapy
Clinical Lymphoma Myeloma & Leukemia·2024
Correlation between number of molecular mutations and outcomes in de novo acute myeloid leukemia.
Journal of Clinical Oncology·2024
Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies.
Journal of Clinical Oncology·2024· 9 cited
Real-world outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with Richter transformation (RT) from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Journal of Clinical Oncology·2024· 5 cited
EPR24-100: A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia Between Appalachian and Non-Appalachian Kentucky
Journal of the National Comprehensive Cancer Network·2024
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
Blood Neoplasia·2024· 3 citedOpen Access
Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of unknown significance: A case report
Clinical Case Reports·2024· 2 citedOpen Access
Bendamustine-Containing Regimens before CAR T-Cell Therapy Have Detrimental Effect on Progression-Free Survival
Transplantation and Cellular Therapy·2024· 3 cited
Pre-Apheresis Cortisol Levels: Does It Correlate to Incidence of CRS?
Transplantation and Cellular Therapy·2024
Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study
Blood·2023Open Access
Systematic Review and Meta-Analysis of Factors Associated with CNS Involvement in Mantle Cell Lymphoma
Blood·2023Open Access
Correlation between Number of Molecular Mutations and Outcomes in De Novo Acute Myeloid Leukemia
Blood·2023
page 1 of 2Next →

Frequent Co-authors

Reinhold Munker(14), Gregory Monohan(14), Ayman Qasrawi(14), Zena Chahine(13), Reshma Ramlal(11), Fevzi Yalniz(11), Hiffsa Taj(7), Alex F. Herrera(6), Trevor Morris(6), Delong Liu(5), Ashley Soule(5), Gerhard Hildebrandt(4), Xitong Zhou(4), C E McAvoy(4), Yanal Alnimer(4), Shundong Cang(3), Sahar Nozad(3), Gary Simmons(3), Jason R. Westin(3), Ryan C. Lynch(3)